| Abstract P125 – Table 1. Patient characteristics and clinical features. Descriptive statistics are presented as median (IQR) and for categorical variables, as counts and proportions. | |
|---|---|
| Characteristics | Total (n = 150) |
| Sex | |
| Female | 8 (5.3) |
| Male | 142 (94.7) |
| Age | |
| Year, median | 37 (32 to 36) |
| HIV transmission route | |
| MSM | 116 (77.3) |
| Heterosexual | 15 (10.0) |
| IVDU | 4 (2.7) |
| NA | 15 (10.0) |
| HIV‐RNA at baseline (copies/mL) | |
| 50 to 200 | 118 (78.7) |
| 201 to 400 | 16 (10.7) |
| 401 to 999 | 16 (10.7) |
| Virological failure has occurred | |
| Yes | 22 (14.7) |
| No | 128 (85.3) |
| CD4 cell count at baseline (cells/μL) | 488.19 (289.76 to 699.86) |
| Time since ART initiation (years) | 3.12 (1.10 to 5.23) |
| Number of ARVs since ART initiation | 4 (3 to 5) |
| Total known number of RNA genotypes | 1 (1 to 2) |
| Duration of follow‐up (months) | 5.13 (2.97 to 8.12) |
IVDU, intravenous drug users; NA, not available.